Sequoia China exceeds target

Despite a drop in venture capital deals across Asia, the firm raised close to $350m for its fourth China fund while OrbiMed, another VC, launches its Asia-focus vehicle.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this